|
FUBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.644360E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.365400E-04 |
| Normal-vs-Stage2 |
1.223200E-01 |
| Normal-vs-Stage3 |
6.349200E-01 |
| Normal-vs-Stage4 |
6.960000E-01 |
| Stage1-vs-Stage2 |
5.777400E-01 |
| Stage1-vs-Stage3 |
8.108100E-02 |
| Stage1-vs-Stage4 |
2.747800E-01 |
| Stage2-vs-Stage3 |
4.047600E-01 |
| Stage2-vs-Stage4 |
5.228000E-01 |
| Stage3-vs-Stage4 |
9.603400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.976200E-03 |
| Normal-vs-AfricanAmerican |
1.182760E-03 |
| Normal-vs-Asian |
6.860800E-01 |
| Caucasian-vs-AfricanAmerican |
3.426200E-01 |
| Caucasian-vs-Asian |
8.355800E-01 |
| AfricanAmerican-vs-Asian |
7.458400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40250000000031E-05 |
| Normal-vs-Female |
9.236200E-01 |
| Male-vs-Female |
2.137800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.183610E-02 |
| Normal-vs-Extreme_Weight |
4.838300E-04 |
| Normal-vs-Obese |
1.466220E-01 |
| Normal-vs-Extreme_Obese |
6.802500E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.921600E-01 |
| Normal_Weight-vs-Obese |
2.094200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.164400E-01 |
| Extreme_Weight-vs-Obese |
6.170400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.895600E-01 |
| Obese-vs-Extreme_Obese |
2.447400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.409400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.062800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.85080000000882E-05 |
| Normal-vs-Age(81-100Yrs) |
1.995200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.664200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.345360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.601450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.662200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.538590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.600500E-04 |
| Normal-VS-Type2 PRCC |
2.938200E-02 |
| Normal-VS-KIRP CIMP |
9.802400E-01 |
| Normal-VS-Unclassified PRCC |
2.897800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.093800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.489180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.483200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.175200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.786800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.570600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.359450E-04 |
| Normal-vs-N1 |
3.756000E-01 |
| Normal-vs-N2 |
3.661000E-01 |
| N0-vs-N1 |
1.302090E-03 |
| N0-vs-N2 |
3.919600E-01 |
| N1-vs-N2 |
3.710800E-01 |
|
|
